The 20-Year Old Study that Shook Medicine

The controversy over clinical trial transparency exploded last week as the BMJ published a reanalysis of previously hidden data on an antidepressant drug called Paroxetine (or Paxil). Paxil was approved for adults in 1992 by the Food and Drug Administration (FDA), but...

Communicating Plant Biology

This is a guest post from Eric Hamilton After four long days at a conference, all you want to do is board a flight home, crawl into bed, and try to forget how your boss saw you dancing at the open-bar party. But on July 30, 2015, a dedicated group of scientists and...

The Story of AllTrials

Almost half of all the clinical trials ever conducted have never been reported. This is the story of the campaign to find them—and to fix medicine. “I felt like I was a mouthpiece for this giant army of disenfranchised nerds,” said Ben Goldacre. It is a bright spring...

WHO: Release All Research Data!

In a further sign of an epochal change in medical research, the World Health Organization has renewed its call for researchers to report all the results from clinical trial research. While there has been great deal of discussion about why clinical trial registration...

Speaking up for Science in Boston

The snowy and frigid temperatures (and the long commutes) didn’t keep people away from our Standing Up for Science media workshop at University of Massachusetts, Boston on February 18. With more over 25 graduate students, post-doctoral fellows and early career...

Clinical Trial Registries: Entering a Brave New Transparent World

It was once the case, said George Mason University’s Giorgio Ascoli, that people thought gene discovery would rapidly lead to the patenting of genes. “Now,” he said, “you can’t publish if your data isn’t in a gene bank.” Ascoli was speaking at Sense About Science’s...